Stock screenerAll disclosures → EDGAR →
QGEN
Conviction 67HealthcareScan · Thu, Sep 24, 2026Qiagen N.v. (QGEN) closed at $44.56 (+1.93%) on Sep 24, 2026. Price is above its 50-day and above its 200-day moving average. RSI(14) 57, RS Rating 62, -20.0% from its 52-week high, -1.4% year to date. Sector: Healthcare · Diagnostics & Research.
QGEN$44.56+1.93%
ResistanceSupportVol 14Vol MA14 1.66M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Price44.56
Change+1.93%
Gap+0.85%
Rel volume0.71×
Avg volume1.69M
Avg $ vol73.47M
SMA 2043.31
SMA 5042.70
SMA 20042.50
Price vs 50+4.35%
Price vs 200+4.84%
MA stackbullish
50/200 crossgolden · 3d
Supertrendup · 41.26
RSI (14)57
MACD hist0.10
MACD crossbull · 3d
Stoch %K / %D81 / 69
ADX (14)11
+DI / −DI26 / 21
RSI divergence—
MACD divergence—
ATR %2.74%
ADR %2.22%
52w high55.66
52w low32.63
From 52w high-19.95%
Above 52w low+36.55%
New 52w highNo
SqueezeOn · 5d
Bollinger width7.44%
%B0.89
Donchian pos80.77%
Donchian high45.23
Donchian low41.74
AVWAP (52w high)42.46
vs AVWAP high+4.94%
AVWAP (52w low)40.34
vs AVWAP low+10.45%
OBV trendUp
Chaikin MF (20)-0.05
Today vs 20d0.71×
Avg vol (14d)1.66M
Avg vol (20d)1.69M
Avg $ vol (20d)73.47M
Market cap9.66B
RS Rating62 / 99
RS 3m (vs SPY)+9.93%
RS 6m (vs SPY)-7.16%
RS line new highNo
Trend template5/8
Technical rank74.4
1 week+0.39%
1 month+2.07%
3 months+14.42%
6 months+9.66%
1 year-2.31%
YTD-1.41%
P/E—
P/B2.56
P/S—
P/FCF—
EPS—
Div yield—
ROE—
ROA—
Debt/Eq0.44
Current3.90
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth—
Price target44.25
Target upside-0.68%
Analyst ratingHold
Institutional75.42%
Ent. value10.48B
Revenue—
Net income—
Gross profit—
Free cash flow—
IndustryDiagnostics & Research
ExchangeNYSE
Shares out206.07M
Employees5.5K
ListedFri, Jun 28, 1996
Free float221.31M
Float %99.6%
Short interest7.51M
Days to cover2.2d
Short volume54.8%
Squeeze score28 / 100
Next earnings—
EPS forecast—
Last EPS vs est$0.62 vs $0.60
Last surprise+3.3% beat
Setup gradeB
Conviction67 / 100
Pattern quality—
Tech rank74.4 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance45.22
Support41.15
Days since event—
Candle confirm—
Congress activity
Disclosed STOCK Act trades in QGEN
No recent disclosed trades by Congress in QGEN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in QGEN
No recent insider (Form 4) filings in QGEN. Insiders must file within two business days of a trade.
SEC filings
EDGAR filings in QGEN · 5 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.